Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling

Xu, W., Zhao, T., Chen, H., Huang, N., Gong, H., Zhang, J., Yu, Y., Li, T., Zhang, G., Gong, C., Yang, M., &amp; Xiao, H. (2022). Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling. <em>Biochemical Pharmacology</em>. https://doi.org/10.1016/j.bcp.2022.115045

Xu W, Zhao T, Chen H, Huang N, Gong H, Zhang J, et al. Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling. Biochemical Pharmacology. 2022. doi:10.1016/j.bcp.2022.115045.

@article{weitong2022PanmTO, title = {Pan-mTOR inhibitors sensitize the senolytic activity of navitoclax via mTORC2 inhibition-mediated apoptotic signaling}, author = {Weitong Xu and Tingting Zhao and Honghan Chen and Ning Huang and Hui Gong and Jian Zhang and Yang Yu and Tiepeng Li and Gongchang Zhang and Chuhui Gong and Ming Yang and Hengyi Xiao}, journal = {Biochemical Pharmacology}, year = {2022}, doi = {10.1016/j.bcp.2022.115045}, }